therapeutic action: azole treatment

Mycobiome analyses of critically ill COVID-19 patients

mycolabadmin

This study examined fungal infections in severely ill COVID-19 patients treated in intensive care units across Europe. Researchers found that a dangerous mold called Aspergillus fumigatus was more common in patients who died and less common in those treated with azole antifungal drugs. The findings suggest that giving antifungal medications to critically ill COVID-19 patients when they arrive at the hospital might help prevent fungal-related deaths.

Read More »

Recognizing the Importance of Public Health Mycology

mycolabadmin

This editorial highlights how fungal infections are a growing but overlooked global health crisis, killing about 2.5 million people annually. The paper brings together seven research articles studying different fungal diseases, from lung infections to skin conditions, showing how these diseases spread differently in different populations and how resistance to antifungal medications is increasing. The authors emphasize that better testing, treatment access, and worldwide disease tracking are urgently needed, especially in poorer countries where the burden of fungal disease is highest.

Read More »
Scroll to Top